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Background: The overall burden of disease (BOD) especially for infectious diseases is higher in Sub-Saharan Africa
than other regions of the world. Existing data collected through the Health Management Information System (HMIS)
may not be optimal to measure BOD. The Infectious Diseases Capacity Building Evaluation (IDCAP) cooperated with
the Ugandan Ministry of Health to improve the quality of HMIS data. We describe diagnoses with associated clinical
assessments and laboratory investigations of outpatients attending primary care in Uganda.
Methods: IDCAP supported HMIS data collection at 36 health center IVs in Uganda for five months (November
2009 to March 2010) prior to implementation of the IDCAP interventions. Descriptive analyses were performed on a
cross-sectional dataset of 209,734 outpatient visits during this period.
Results: Over 500 illnesses were diagnosed. Infectious diseases accounted for 76.3% of these and over 30% of visits
resulted in multiple diagnoses. Malaria (48.3%), cough/cold (19.4%), and intestinal worms (6.6%) were the most
frequently diagnosed illnesses. Body weight was recorded for 36.8% of patients and less than 10% had other clinical
assessments recorded. Malaria smears (64.2%) and HIV tests (12.2%) accounted for the majority of 84,638 laboratory
tests ordered. Fewer than 30% of patients for whom a laboratory investigation was available to confirm the clinical
impression had the specific test performed.
Conclusions: We observed a broad range of diagnoses, a high percentage of multiple diagnoses including true
co-morbidities, and underutilization of laboratory support. This emphasizes the complexity of illnesses to be
addressed by primary healthcare workers. An improved HMIS collecting timely, quality data is needed. This would
adequately describe the burden of disease and processes of care at primary care level, enable appropriate national
guidelines, programs and policies and improve accountability for the quality of care.
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Despite recent reductions in both morbidity and mortality,
the burden of diseases (BOD) in Sub-Saharan Africa (SSA)
remains high when compared with the rest of the world,
particularly due to the high burden of infectious diseases
[1]. While malaria, tuberculosis and HIV/AIDS remain the
leading causes of illness and death in the region, maternal
and neonatal complications, diarrheal diseases, pneumo-
nia, and malnutrition are drivers of ‘health loss’, particu-
larly in children [1]. Concurrently, there has also been an* Correspondence: mbonyemarti@yahoo.com
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unless otherwise stated.increase in BOD due to non-communicable diseases
(NCD) in adults [1-7].
Little is know about the spectrum of clinical diagnoses
encountered at primary care facilities in many SSA coun-
tries, including Uganda. Organizations such as the World
Bank, the Institute for Health Metrics and Evaluation [1],
the World Health Organization [7], and others [2-5]
utilize routine health information systems, alongside na-
tional representative household surveys and health and
demographic surveillance sites, for assessing, estimating
and documenting global, regional, country and disease
specific BOD [8]. Well collected and analyzed data inform
clinical decision support systems [9,10], and enable assess-
ment of disease risk, setting of priorities, evaluations of
cost-effectiveness [11] and program efficiency [12], and
national planning and policy formulation [13].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the Health Management Information System (HMIS)
[14,15] at all levels of the health system. The Medical Form
Five (MF5) acts as the case record form and is used to
document individual patient data during visits to the out-
patient department. Data collected using the MF5 are tran-
scribed into the patient registers, which stay at the health
facilities while the original MF5 is retained by the patient
[15]. These notes guide patient management during subse-
quent visits. On a monthly basis, data in the patient regis-
ters are aggregated and forwarded to the district and the
Ministry of Health (MoH). The Uganda MoH Resource
Centre has the overall responsibility for processing national
data collected through the HMIS and use these data to
compile annual health sector performance reports [16]
statistical abstracts [17] and policy formulation.
Although HMIS data could be a powerful resource for
estimating the BOD and developing clinical decision sup-
port systems [18,19], its use has been limited by quality
limitations, such as underreporting, data loss during ag-
gregation, and erroneous diagnoses [20-25].
The Integrated Infectious Disease Capacity Building
Evaluation (IDCAP) sought to estimate the effect of a
training program followed by on-site support (OSS) [26]
on individual clinical competence [27] and practice,
facility-level performance [28,29], and population-based
mortality of children under five. To measure facility per-
formance, the IDCAP evaluation team cooperated with
the Uganda MoH to improve the quality of HMIS data
through provision of data entry staff and equipment,
training and support of supervision visits [30].
We present a review of outpatient visit records from pri-
mary care facilities in Uganda from November 2009 to
March 2010. While these visits were primarily intended to
serve as a baseline for the IDCAP training and quality im-
provement interventions, they provide a patient-level data-
set to examine the potential of using a strengthened
HMIS to estimate the BOD.
This article describes outpatient demographic charac-
teristics, common symptoms, investigations, diagnoses
and multiple diagnoses recorded in the MF5. It also
demonstrates the limitations of clinical diagnosis.
Methods
Study objectives
To describe diagnoses, multiple diagnoses or comorbidi-
ties, clinical assessments and the extent to which diagnoses
are confirmed by laboratory investigations among outpa-
tients presenting at primary care facilities in rural Uganda.
Study design
This is a cross sectional study that analyzes baseline data
collected prior to a large mixed design intervention study
described in Naikoba et al. [30]. After these baseline datawere collected, two IDCAP interventions were imple-
mented 1) the Integrated Management of Infectious Dis-
eases (IMID) course and 2) on-site support. IMID was for
two selected mid-level practitioners (mainly clinical offi-
cers and registered nurses) from each of the 36 health fa-
cilities conducted at the Infectious Diseases Institute,
Makerere University (IDI). It involved a three-week class-
room based core course, followed by two one-week
booster courses at 12 and 24 weeks after the core course
as described in Miceli et al. [26]. On-site support was
training and continuous quality improvement which took
place at a random sample of 18 of the 36 health facilities.
All health workers were invited to participate in the on-
site support training as described in Naikoba et al. [30]
and Miceli et al. [26].
Study sites and participants
IDCAP was implemented at 36 health center IVs (HCIV)
or comparable health facilities from all administrative
regions of Uganda, as depicted in a map in Figure 1, that
met the inclusion criteria [30]. The government of
Uganda managed thirty sites, five were private not-for-
profit sites and one was a private for-profit site with gov-
ernment subsidies. Five sites are small hospitals while 31
are HCIVs. All are the highest healthcare referral point
for a health sub-district [31,32]. Each is expected to
serve a population of about 100,000 people in the health
sub-district, providing basic preventive, curative and re-
ferral services with limited inpatient wards. HCIVs also
conduct some emergency and surgical and obstetric pro-
cedures [17,32]. Staffing norms and level of staffing for a
HCIV can be obtained from the 2010 MoH Human Re-
sources for Health Audit Report [33]. Participants in-
cluded all outpatients at these health facilities.
Data collection, entry and validation
Data were collected using the MF5 depicted in Figure 2,
which was initially modified by the Uganda Malaria Sur-
veillance Project [12] and further revised by IDCAP [28],
and includes links between clinical and laboratory data,
and ‘tick boxes’ for history, laboratory investigations,
diagnoses and drug prescriptions.
Prior to collecting data, a team comprised of a data
management specialist, a medical officer, a clinical officer
and a nursing officer introduced the MF5 at each health
facility during a one-day training for all health workers.
Two key training activities were: 1) an explanation of all
variables on the MF5 and the process of collecting out-
patient data, and 2) a practical session with the form dur-
ing routine care. At the end of the day, the health workers
met with the trainers to share experiences and offer sug-
gestions to optimize use of the MF5 within the conditions
unique to each health facility. Four training teams were
created with each team supporting nine health facilities.
Figure 1 Map of Uganda showing location of IDCAP sites. It is a map of Uganda showing location of all the health facilities that participated
in the IDCAP study.
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on November 1, 2009. The MF5 collected patient data
at various points of care; data on triage and patientdemographics at the reception, data on illness history,
diagnosis, treatment and referral from the clinician, data
on diagnostic investigations and results from laboratory
Figure 2 The Medical Form 5 used during IDCAP data collection. It is the revised Uganda Ministry of Health Outpatient Medical Form used
to capture patient’s data during routine care.
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or pharmacist.
Data were entered into EpiInfo 3.2® (Centers for Disease
Control and Prevention, Atlanta GA, US) and transmitted
to the central database at the IDI for aggregation, cleaning
and analysis. A team of laboratory technicians and clini-
cians at the IDI supported data cleaning and coding of
diagnoses guided by the ICD-10. The process of data col-
lection, entry and validation has been explained previously
in more detail [28].
Statistical analysis
Frequencies and percentages were used for most ana-
lyses while cross tabulations were performed to establish
relationships between different variables of interest. Al-
though 238,248 patient visits occurred during the data
collection period, 28,514 (12%) MF5s with no record of
age or sex variables were excluded, leaving 209,734 re-
cords for analysis. All statistical analyses were performed
using Stata version 11.0 (StataCorp LP, College Station
TX, 2009), and Microsoft Office Excel 2007 (Microsoft
Corporation, Redmond WA, 2007).
Ethics Statement
The original IDCAP protocol was reviewed and approved
by the School of Medicine Research and Ethics Committee
of Makerere University and the Uganda National Council
for Science and Technology. Data collected for the HMIS
were part of routine reporting at health facilities and did
not require informed consent. The University of Washing-
ton Human Subjects Division determined that IDCAP did
not meet the regulatory definition of research under 45
CFR 46.102(d). This secondary analysis of anonymous data
was also exempt from review by the University of Antwerp
ethical review board. Anonymous data are available for
public use and instructions for requesting them are on the
Accordia Global Health Foundation website (http://www.
accordiafoundation.org/IDCAP/data).
Results
Demographic characteristics, symptoms and exams per-
formed and a summary of diagnosis and treatment deci-
sions for 209,734 patient visits with acute presentations
relating to illness or injury are summarized in Table 1. Of
these, 181,529 (97.1%) were initial presentations for un-
scheduled appointments. While male and female infants
and children under five were equally likely to visit the
HCIVs (30,311 vs. 30,381 visits), there were 46.9% more
visits for females aged 14–49 years (85,138 vs. 45,177
males). Triage status according to the World Health
Organization (WHO) Emergency Triage, Assessment and
Treatment (ETAT) guidelines [34] were recorded for only
67,997 (32.4%) visits, of which 6,936 (10.2%) had ‘danger
signs’ requiring immediate assessment and treatment.Few patients had their clinical exams recorded: Body
weight (77,141; 36.8%), temperature (13,820; 6.6%)
height (50; 0.024%) and blood pressure (BP) (1,769;
0.85%). BP recording was often done for older patients
(3.9% among patients 50 or more years) compared to
younger patients (1.1% among patients 14–49 years and
0.04% among patients less than five years).
The most frequently reported symptoms were fever,
which was recorded in 89,596 (42.7%) visits, of which
only 2,041 (2.3%) were confirmed by a thermometer
(>37.5°C) and cough which was recorded in 54,851
(26.1%) visits, of which 7,029 (12.8%) was prolonged for
two or more weeks.
Among three assessments for pneumonia recorded in
the MF5, breathing rate and abnormal chest sounds
were respectively assessed in 101 (0.18%) and 2,043
(3.7%) of 54,851 patients with a cough, while chest in-
drawing was assessed in 869 (3.5%) of 24,960 children
less than five years with a cough.
Among the three assessments for tuberculosis, night
sweats and weight loss were respectively assessed in
17.5% and 19.2% of 7,029 patients with a cough for two
or more weeks. Child contact with a TB case was
assessed in 474 (11.1%) of 4,257 children less than
14 years with a cough for two or more weeks.
Overall, 180,492 (86.1%) visits had at least one diagno-
sis identified on the MF5, 203,193 (96.9%) received a
drug prescription, 10,743 (5.1%) were admitted for fur-
ther care, 3,963 (1.9%) were referred elsewhere for fur-
ther care and 297 (0.14%) were detained for a short time
for close monitoring.
Diagnosis
Overall, over 500 distinct diagnoses (see Additional file
1) were made. Infectious diseases (76.3%) were the com-
monly diagnosed illnesses, followed by NCD (10.9%) and
diagnoses that could not be determined according to the
ICD-10 (10.6%) (Table 2). Illnesses that could not be de-
termined according to the ICD-10 included: fatigue,
vomiting and nausea, dizziness, and unspecified pain
among others.
Similarly, for any specific diagnosis that required a la-
boratory investigation, fewer than 30% of patients were
confirmed by a diagnostic test (Table 3). For example, only
17.8% of 101,266 malaria diagnoses were confirmed.
For diagnoses where national statistics were available,
our sample of 36 HCIVs had comparable prevalence
(Table 3). Malaria (48.3%), cough/cold (19.4%), and in-
testinal worms (6.6%) were the commonly diagnosed
illnesses.
For each of the top 20 commonly diagnosed illnesses,
more females were diagnosed with illnesses than males,
with exception of injuries and trauma (Female to Male ra-
tio: 0.9). In some instances, female diagnoses were more
Table 1 Characteristics of outpatients
Parameters
Male (N = 82,626) Female (N = 127,108) Total (N = 209,734)
N (%) N (%) N (%)
Age
< 1 month (Neonates) 336 (0.4) 364 (0.3) 700 (0.3)
1 – 11 months 8,996 (10.9) 9,018 (7.1) 18,014 (8.6)
1 – 4 years 20,979 (25.4) 20,999 (16.5) 41,978 (20.0)
5 – 13 years 15,568 (18.8) 20,004 (15.7) 35,572 (17.0)
14 – 49 years 29,609 (35.8) 65, 134 (51.2) 94,743 (45.2)
50+ 7,138 (8.6) 11,589 (9.1) 18,727 (8.9)
Total attendance
New visits 70,973 (85.9) 110,556 (87.0) 181,529 (86.6)
Repeat visits 2,310 (2.8) 3,051 (2.4) 5,361 (2.6)
Missing data 9,343 (11.3) 13,501 (10.6) 22,844 (10.9)
Triage status recorded‡
Standard 19,178 (23.2) 30,482 (24.0) 49,660 (23.7)
Priority 4,542 (5.5) 6,859 (5.4) 11,401 (5.4)
Emergency 2,909 (3.5) 4,027 (3.2) 6,936 (3.3)
Missing data (no triage data recorded) 55,997 (67.8) 85,740 (67.4) 141,737 (67.6)
Symptoms recorded
Fever 37,254 (45.1) 52,342 (41.2) 89,596 (42.7)
No fever 5,164 (6.2) 8,886 (7.0) 14,050 (6.7)
Data not recorded on fever 40,210 (48.7) 65,880 (51.7) 106,088 (50.6)
Cough 22,890 (27.7) 31,961 (25.1) 54,851 (26.2)
Cough < 2 weeks 19,792 (24.0) 27,589 (21.7) 47,381 (22.6)
Cough > =2 weeks 2,908 (3.5) 4,121 (3.2) 7,029 (3.4)
Cough (not duration not determined) 190 (0.2) 251 (0.2) 441 (0.2)
No cough 8,857 (10.7) 14,297 (11.2) 23,144 (11.0)
Data not recorded on cough 50,881 (61.6) 80,850 (63.6) 131,739 (62.8)
Abnormal chest sounds among patients with a cough 88 (0.3) 104 (0.3) 192 (0.4)
No abnormal chest sounds 764 (3.3) 1,087 (3.4) 1,851 (3.4)
No data on abnormal chest sounds 22,038 (96.3) 30,770 (96.3) 52,808 (96.3)
Breaths per minute among patients with a cough 51 (0.2) 50 (0.2) 101 (0.2)
No data on breaths per minute 22,839 (99.8) 31,911 (99.8) 54,750 (99.8)
Chest in drawing among children under five with a cough 67 (0.5) 70 (0.6) 137 (0.5)
No chest in drawing 364 (2.9) 368 (2.9) 732 (2.9)
Missing data on chest in drawing 12,023 (96.5) 12,068 (96.5) 24,091 (96.5)
Night sweats among patients with cough > =2 weeks 152 (5.2%) 147 (3.6) 299 (4.3)
No night sweats 372 (12.8) 560 (13.6) 932 (13.3)
No data on night sweats 2,384 (82.0) 3,414 (82.8) 5,798 (82.5)
Weight loss among patients with cough > =2 weeks 138 (4.7) 114 (2.8) 252 (3.6)
No weight loss 446 (15.3) 651 (15.8) 1,097 (15.6)
No data on weight loss 2,324 (79.9) 3,356 (81.4) 5,680 (80.8)
Child under 14 with a cough > =2 weeks in contact with a TB case 37 (0.22) 43 (0.23) 80 (0.23)
Child not in contact with a TB case 2,802 (16.6) 3,920 (21.1) 6,722 (19.0)
No data on child contact with a TB case 14,005 (83.2) 14,783 (78.7) 28,618 (81.0)
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Table 1 Characteristics of outpatients (Continued)
Exams recorded
Temperature 5,688 (6.9) 8,132 (6.4) 13,820 (6.6)
Weight 30,980 (37.5) 46,161 (36.3) 77,141 (36.8)
Blood Pressure 522 (0.63) 1,247 (0.98) 1,769 (0.84)
Height 21 (0.03) 29 (0.02) 50 (0.02)
No symptom and exam checkboxes filled 33,915 (41.1) 55,009 (43.3) 88,924 (42.4)
Diagnosis and treatment decisions
Diagnosis recorded 70,721 (85.6) 109,771 (86.4) 180,492 (86.1)
Treatment prescribed 79,639 (96.4) 123,554 (97.2) 203,193 (96.9)
Referred for further care 1,712 (2.1) 2,251 (1.8) 3,963 (1.9)
Detained for monitoring 127 (0.16) 170 (0.13) 297 (0.14)
Admitted 5,086 (6.2) 5,657 (4.5) 10,743 (5.1)
‡Triage status was established according to the World Health Organization Emergency Triage, Assessment and Treatment (ETAT) guidelines.
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mitted infections, gastrointestinal (GI) disorders, high BP
and arthritis).
Many of the diagnoses were evenly distributed across
age groups with some exceptions (see Additional file 2).
Malaria (median age = 10 years), diarrhea (median age =
1 year), pneumonia (median age = 3 years) and anemia
(median age = 2 years) were often diagnosed among
younger patients, while arthritis (median age = 44 years)
and high BP (median age = 55 years) were often diag-
nosed among older patients.
Several cases of diseases of epidemic potential were re-
ported with dysentery (915, 0.44%) the most frequently
diagnosed. Acute flaccid paralysis was diagnosed in 77
patients; meningococcal meningitis in 66; measles in 45
and yellow fever in 17. The top five most prevalent
neglected tropical diseases included 78 cases of schisto-
somiasis; 45 of leprosy; 44 of filariasis (general); 31 of
onchocerciasis and 19 of guinea worm.
The top 5 NCD appeared among the top 20 commonly
diagnosed illnesses with the commonest being: miscel-
laneous GI disorders 11,519 (5.5%), injuries/traumaTable 2 Summary of disease episodes by category of
disease diagnosed
Disease category N (%), n = 254,983
Infectious/communicable diseases 194,492 (76.3)
Non communicable diseases & injuries 27,891 (10.9)
Diagnosis not determined according to the ICD-10 27,081 (10.6)
Indeterminate/ineligible diagnosis (diagnosis was
written on the MF5 but could not be understood)
3,348 (1.3)
Diseases of epidemic potential 1,189 (0.5)
Maternal and perinatal conditions 760 (0.3)
Neglected tropical diseases 222 (0.1)4,618 (2.2%), anemia 1,515 (0.7%), high BP 1,437 (0.7%)
and arthritis 1,074 (0.5%).
Laboratory investigations
Table 4 shows the distribution of commonly conducted
laboratory tests, results, and link between positive/ab-
normal results and diagnosis for related illnesses.
Overall, 84,638 laboratory tests were ordered during
56,117 (28.8%) visits. Not all tests done had results re-
corded (range: 50% for sickle cell tests and 91.4% for
CATT). Of the 48,280 malaria tests with results, 22,806
(47.2%) were positive for malaria. Although malaria
(48.5%) topped the disease prevalence list, only 17.8% was
confirmed (Table 3). While 10,321 patients were offered
an HIV test, the test was not conducted for 20 of them. Of
the 10,301 HIV tests conducted, 8,768 (85.1%) had a result
recorded, of which 844 (9.6%) were positive. Two tests
(VDRL and RPR) to determine syphilis and other STIs
were done of which 16.6% and 12.2% respectively were
positive. For urinalysis and stool analysis, 43.2% and 28.8%
of the tests done indicated a positive result, while 79.4% of
2,608 hemoglobin tests with results indicated anemia.
Usually, patients who test positive for malaria should
be assessed for anemia. Additional analysis showed that,
among the 22,806 patients with a positive smear result
for malaria, only 1,438 (6.3%) had hemoglobin measured
of which 1,188 (82.6%) were anemic.
Generally, apart from malaria (79.1%), a lot of posi-
tive/abnormal test results did not have a record of diag-
nosis for a related illness.
Multiple diagnoses and comorbidities
Among the 180,492 (86.1%) outpatient visits with diagno-
ses, 63,414 (35.1%) had multiple diagnoses (Table 3). For
example, of the 101,266 malaria diagnoses, 48,954 (48.3%)
had additional diagnoses. Table 5 reports comorbidities














N % (95% CI)
Top 20 diagnoses
1 Malaria 47.3 101,266 48.3 (48.1, 48.5) 10 1.47 18,051 (17.8) 48,954 (48.3)
2 Cough or cold 23.7 40,669 19.4 (19.2, 19.6) 9 1.48 N/A 27,295 (67.1)
3 Intestinal worms 6.4 13,892 6.6 (6.5, 6.7) 13 1.61 198 (1.4) 10,525 (75.8)
4 GI disorders* 2.8 11,519 5.5 (5.4, 5.6) 30 2.32 N/A 6,347 (55.1)
5 Pneumonia 3.2 8,335 3.9 (3.9, 4.1) 3 1.21 N/A 6,003 (72.0)
6 Diarrhea 3.6 8,137 3.9 (3.8, 4.0) 1 1.15 N/A 6,409 (78.8)
7 Skin diseases 3.7 8,028 3.8 (3.7, 3.9) 12 1.26 N/A 3,689 (46.0)
8 Urinary Tract Infection 2.3 7,043 3.4 (3.3, 3.4) 27 1.99 500 (7.1) 3,886 (55.2)
9 Oral diseases _ 4,832 2.3 (2.2, 2.4) 21 1.48 N/A 1,146 (23.7)
10 Injuries, Trauma* _ 4,618 2.2 (2.1, 2.3) 22 0.90 N/A 1,095 (23.7)
11 Eye conditions 2.4 3,782 1.8 (1.7, 1.9) 16 1.20 N/A 1,736 (45.9)
12 Ear Nose & Throat Conditions _ 3,762 1.8 (1.7, 1.9) 17 1.62 N/A 1,787 (47.5)
13 Pelvic Inflammatory Disease _ 3,486 1.7 (1.6, 1.7) 30 N/A N/A 1,790 (51.4)
14 Sexually Transmitted Infections 2.8 3,338 1.6 (1.5, 1.7) 28 2.19 117 (3.5) 1,491 (44.6)
15 Anemia* _ 1,515 0.72 (0.69, 0.76) 2 1.19 408 (27.0) 1,307 (86.3)
16 Cardiovascular – High Blood Pressure* _ 1,437 0.69 (0.65, 0.73) 55 2.76 N/A 748 (52.1)
17 Typhoid fever _ 1,390 0.66 (0.63, 0.70) 25 1.52 302 (21.7) 829 (59.6)
18 HIV/AIDS _ 1,275 0.61 (0.58, 0.64) 32 1.82 251 (19.7) 720 (56.5)
19 Asthma* _ 1,095 0.52 (0.49, 0.55) 36 1.58 N/A 475 (43.4)
20 Arthritis, all cases _ 1,074 0.51 (0.48, 0.54) 46 2.43 N/A 453 (42.2)
Top 5 diseases of epidemic potential
1 Dysentery 0.37 915 0.44 (0.41, 0.47) 14 1.24 41 (4.5) 558 (61.0)
2 Acute Flaccid paralysis 0.00 77 0.04 (0.03, 0.05) 15 2.67 N/A 60 (77.9)
3 Meningitis (Meningococcal) 0.00 66 0.03 (0.02, 0.04) 13.5 0.89 0 (0) 23 (34.9)
4 Measles 0.00 45 0.02 (0.015, 0.028) 2 0.8 N/A 33 (73.3)
5 Yellow Fever 0.00 17 0.01 (0.004, 0.012) 16 1.83 N/A 9 (52.9)
Top 5 neglected tropical diseases
1 Schistosomiasis _ 78 0.04 (0.03, 0.04) 18.5 1.33 4 (5.1) 58 (74.4)
2 Leprosy _ 45 0.021 (0.02, 0.03) 40 1.00 0 (0) 32 (71.1)
3 Filiarisis _ 44 0.021 (0.01, 0.03) 40 2.39 0 (0) 27 (61.4)
4 Onchocerciasis _ 31 0.015 (0.01, 0.02) 25 2.88 1 (3.2) 17 (54.8)
5 Guinea worms _ 19 0.009 (0.001, 0.01) 11 1.71 N/A 13 (68.2)
Top 5 maternal and perinatal conditions‡
1 Abortion _ 298 0.14 (0.13, 0.16) 24.0 N/A N/A 89 (29.9)
2 Perinatal conditions in newborns _ 81 0.04 (0.03, 0.05) 0.00 0.98 N/A 18 (22.2)
3 Puerperal sepsis _ 43 0.02 (0.01, 0.02) 25.0 N/A N/A 16 (37.2)
4 Pregnancy _ 43 0.02 (0.01, 0.02) 22.0 N/A 3 (7) 13 (30.2)
5 Ovarian cyst _ 35 0.02 (0.01, 0.02) 30.0 N/A N/A 18 (51.4)
*Top 5 Non-Communicable Diseases.
**Percent is the proportion of patients with any given diagnosis who also had at least one other diagnosis.
†National MOH statistics are not available for all diagnoses.
‡Data only represents maternal and perinatal conditions that presented in the outpatient department; most patients with these conditions present at the
specialized maternal and child health clinics including, antenatal, maternity and postnatal clinics.
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Table 4 Laboratory investigations conducted: top 15 laboratory tests




N (%) N (%) N (%) N (%)
1 Malaria Test (Blood Smear or RDT) 54,344 (64.2) 48,280 (88.8) 22,806 (47.2) 18,051 (79.1)
2 HIV Test (Rapid Test or DNA PCR) 10,301 (12.2) 8,768 (85.1) 844 (9.6) 251 (29.7)
3 Urinalysis 4,672 (5.5) 3,125 (66.9) 1,349 (43.2) 702 (52.0)
4 Stool Analysis 3,713 (4.4) 2,252 (60.7) 648 (28.8) 414 (63.9)
5 Hemoglobin (Hb) 3,467 (4.1) 2,608 (75.2) 2,071 (79.4) 408 (19.7)
6 VDRL (Venereal Disease Research Lab test) 2,361 (2.8) 1,812 (76.7) 300 (16.6) 31 (10.3)
7 Widal 2,273 (2.7) 1,565 (68.9) 480 (30.7) 302 (63.0)
8 TB AFB Smear 1,347 (1.6) 757 (56.2) 113 (14.9) 60 (53.1)
9 BAT (Brucella Agglutination Test) 808 (1.0) 569 (70.4) 59 (10.4) 30 (50.9)
10 Pregnancy Test 306 (0.4) 258 (84.3) 107 (41.5) 3 (2.8)
11 Random Blood Sugar 234 (0.3) 176 (75.2) 50 (28.4) 25 (50.0)
12 Blood Grouping and/or Blood Cross March 225 (0.3) 188 (73.7) N/A N/A
13 RPR (Rapid Plasma Reagin Test) 80 (0.1) 57 (71.3) 7 (12.2) 2 (28.6)
14 CATT (Card agglutination test for trypanasomiasis) 81 (0.1) 74 (91.4) 5 (6.8) 0 (0)
15 Sickle cell test 64 (0.1) 32 (50.0) 5 (15.6) 1 (20.0)
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http://www.biomedcentral.com/1471-2296/15/165among the 10 most commonly diagnosed illnesses. The
bold text across the diagonal of the table presents mono
diagnoses. Column and row percentages are presented in
the upper and lower parts of the diagonal of the table re-
spectively. For example, in the upper diagonal (column
percentages) of the table, 22,217 (55.6%) of the 40,669
cough or cold cases were also diagnosed with malaria
while in the lower diagonal, 22,217 (21.9%) of the 101,266
malaria cases were also diagnosed with cough or cold.
Among the top 10 diagnoses reported in Table 5, there
was a disproportionate overlap among malaria, cough/
cold, pneumonia and diarrhea. In 8,335 patients diagnosed
with pneumonia and 8,137 with diarrhea, 5,302 (63.6%)
and 4,822 (59.3%) respectively were also diagnosed with
malaria. Similarly, a high proportion of patients with diar-
rhea were also diagnosed with cough/cold (23.1%). Of
those diagnosed with intestinal worms or urinary tract in-
fections, there was a high percentage also diagnosed with
GI problems (6.1% and 5.6%, respectively).
Discussion
This study, which included 209,734 visits across 36
health facilities, presents a panoramic view of primary
care provided in Uganda. Infants and children under five
appeared to have equal access to care, regardless of gen-
der, in contrast to some societies where males are dis-
proportionately represented in the under-five population
receiving care [35]. In the population 14–49 years,
women predominated, with ratio of over 2:1, possibly
reflecting men’s reluctance to seek care.The disease prevalence pattern found in this study
matches national patterns where data is available, with
malaria (48.3%), cough or cold (19.4%), and intestinal
worms (6.6%) being the most prevalent illnesses [17].
The observed malaria prevalence (47.2%) among those
with confirmed malaria was also comparable to the com-
munity parasitemia prevalence reported in the 2009
Uganda malaria indicator survey [36]. The patterns of
commonly reported illnesses found in this study are also
similar to those observed in most SSA countries outside
of Uganda [1]. This study also provides the prevalence of
less common infections that are rarely reported.
Although 1,189 (0.5%) infections of epidemic potential
were identified during this period, little is known about
investigations done to confirm these diagnoses or con-
trol measures instituted. Reports from primary health-
care providers are essential for the early recognition and
control of reportable infectious diseases that may place
populations at high risk of life threatening epidemics
[37]. Ebola outbreaks have occurred on four occasions
during the past decade in Uganda and early recognition
limited the epidemics. Rapid analysis of HMIS data
could identify epidemics early to curtail and control
these outbreaks [37-39].
At 10.9% of total diagnoses, NCD and injuries in
Uganda are increasingly becoming an important public
health concern, as in the rest of SSA countries [1-7].
Stroke (600–2400 DALYs lost per 100,000) and heart
disease (300–600 DALYs lost per 100,000) are rapidly in-
creasing causes of death and disability in SSA, with
Table 5 Multiple diagnoses among each of the top 10 diagnoses

















Malaria 52,312 (51.7%) 22,217 (54.6%) 6,903 (49.7%) 3,200 (27.8%) 5,302 (63.6%) 4,822 (59.3%) 1,866 (23.2%) 2,043 (29.0%) 677 (14.0%) 426 (10.2%) 101,266
Cough or cold 22,217 (21.9%) 13,374 (32.9%) 2,559 (18.4%) 1,180 (10.2%) 0 (0.0%) 1,877 (23.1%) 794 (9.9%) 369 (5.2%) 286 (5.9%) 191 (4.6%) 40,669
Intestinal worms 6,903 (6.8%) 2,559 (6.3%) 3,367 (24.2%) 845 (7.3%) 465 (5.6%) 657 (8.1%) 562 (7.0%) 505 (7.2%) 71 (1.5%) 72 (1.7%) 13,892
Gastro Intestinal
disorders
3,200 (3.2%) 1,180 (2.9%) 845 (6.1%) 5,172 (44.9%) 153 (1.8%) 191 (2.3%) 207 (2.6%) 394 (5.6%) 58 (1.2%) 71 (1.7%) 11,519
Pneumonia 5,302 (5.2%) 0 (0.0%) 465 (3.3%) 153 (1.3%) 2,332 (28.0%) 349 (4.3%) 113 (1.4%) 82 (1.2%) 53 (1.1%) 19 (0.5%) 8,335
Diarrhea 4,822 (4.8%) 1,877 (4.6%) 657 (4.7%) 191 (1.7%) 349 (4.2%) 1,728 (21.2%) 134 (1.7%) 79 (1.1%) 92 (1.9%) 18 (0.4%) 8,137
Skin diseases 2,049 (2.0%) 794 (2.0%) 562 (4.0%) 207 (1.8%) 113 (1.4%) 134 (1.6%) 4,339 (54.0%) 125 (1.8%) 53 (1.1%) 85 (2.0%) 8,028
Urinary tract infections 2,043 (2.0%) 369 (0.9%) 505 (3.6%) 394 (3.4%) 82 (1.0%) 79 (1.0%) 125 (1.6%) 3,157 (44.8%) 28 (0.6%) 26 (0.6%) 7,043
Oral diseases 677 (0.7%) 286 (0.8%) 71 (0.5%) 58 (0.5%) 53 (0.6%) 92 (1.1%) 53 (0.7%) 28 (0.4%) 3,686 (76.3%) 5 (0.1%) 4,832
Injuries/Trauma 426 (0.4%) 191 (0.5%) 72 (0.5%) 71 (0.6%) 19 (0.2%) 18 (0.2%) 85 (1.1%) 26 (0.4%) 5 (0.1%) 3,073 (73.7%) 4,168
Overall total 101,266 40,669 13,892 11,519 8,335 8,137 8,028 7,043 4,832 4,168 209,734
The bold figures across the table diagonal show mono diagnoses.
The percentages in the upper section of the table diagonal are column percentages and are calculated by dividing the number of patients (N) by the column total.
The percentages in the lower section of the table diagonal are row percentages and are calculated by dividing the number of patients (N) by the row total.
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http://www.biomedcentral.com/1471-2296/15/165much of this tragic outcome possibly due to longstand-
ing, untreated hypertension [2,6,40-42]. While diagnosis
and treatment of hypertension are cost-effective and
feasible within primary care, care for chronic illnesses in
general requires radically different strategies, including
an emphasis on patient education to facilitate treatment
adherence, retention in care, and periodic tests of care
effectiveness. Given that only 2.6% of the visits were
follow-up for ongoing illnesses, and 0.8% of the patients
had their BP recorded, further efforts and strategies will
be needed to build capacity to care for chronic diseases
and health outcomes generally [43].
The prevalence of multiple diagnoses or comorbidities
among patients diagnosed with malaria, respiratory in-
fections and diarrhea was high and comparable to other
recent studies from SSA [1]. In our study, 30.2% of all
patients and 38.9% of patients less than five years had
multiple diagnoses, which is higher than findings from a
Tanzania study [44] where it was 22.6% among young
outpatients. Overlap in diagnoses was commonest in pa-
tients with malaria, cough/cold, pneumonia, diarrhea
and intestinal infections. Of those diagnosed with mal-
aria, our study found that 21.9% were also diagnosed
with cough/cold and 5.2% with pneumonia, compared to
respectively 29.5% and 7.6% in Tanzania [44]. This rate
of malaria and pneumonia co-infection in young chil-
dren is much lower than the 37% reported in a study
done 10 years ago in Uganda [45]. In western Kenya
[46], 28% of children with respiratory viral infections
had malaria, which is much lower than in 61.4% of chil-
dren with cough/cold in our study. These data illustrate
the difficulties in making a differential diagnosis between
malaria, pneumonia and even a gastrointestinal infection
in situations when recommended clinical and laboratory
assessments are not routinely performed. Few studies
have however examined comorbidities or multiple diag-
noses among outpatient populations in SSA [21,45,47].
In order to make these diagnoses, it is expected that
clinicians will take a patient’s history and conduct basic
physical assessment. Clinical history was recorded only
57.6% of the time and limited use of clinical assessment
tools was observed. Weight was recorded in only 38.8%
of patients more than two years old, 53.8% of patients
aged one month to two years, and 38.1% of neonates.
Only 2.1% of adults aged 14 or more years had a BP re-
corded. Proper clinical assessments are critical to ensuring
high quality of care, but are rarely conducted in SSA. In
an era where NCD prevalence in SSA is increasing [1-7],
failure to screen for BP [48] and body mass index is a
missed opportunity in assessing a patients’ potential risk.
Despite laboratory confirmations being one of the most
important mechanisms for clinicians to provide more
accurate diagnoses, laboratory diagnostics were rarely
used, with less than 30% of patients receiving laboratoryconfirmation for diagnoses requiring an investigation. All
sites had trained laboratory technicians and a functional
laboratory that could conduct at least six investigations
(HIV rapid tests, malaria blood smears, TB sputum
smears, urinalysis, stool analysis, and hemoglobin estima-
tion) [30]. When the laboratory investigations were or-
dered results were recorded only 50.0% to 91.4% of the
time. These rates of recording differed by laboratory test
with malaria test results most often recorded and sickle
cells test least often. Laboratory personnel may prioritize
tests that are faster to conduct or those that are more
common and can easily be done in batches. At the same
time, patients may be less inclined to wait for results that
take longer to be recorded. As such, tests that are carried
out more quickly are more likely be recorded on the MF5
and returned to the clinician for a diagnosis.
Even when results were recorded, clinicians often ap-
peared to lack confidence in the results. Apart from
malaria (79.1%), many patients with a positive test re-
sult did not have a record of a diagnosis for a related ill-
ness. Further investigations are needed to determine
reasons for this difference. It is also clear many diagno-
ses that required a laboratory confirmation were made
without them given that only 28.8% of visits for whom
a laboratory investigation was needed and available to
confirm the clinical impression had the specific labora-
tory test performed. This underuse of laboratory diag-
nostics may be leading to many missed or incorrect
diagnoses [49,50].
Strengthening of laboratory resources has been previ-
ously identified as an important priority in improving
health services [24]. Increasing the use of laboratory ser-
vices requires an appreciation of their value, as well as
confidence in their reports [51,52]. Between 2006 and
2012, IDI implemented two projects, Joint Uganda Mal-
aria Training Program and IDCAP, in which they trained
clinicians, nurses and laboratory personnel in optimal
management of malaria and other infectious illnesses.
The training also encouraged shared problem solving
and appreciation for each other’s contribution to man-
aging the patient. Results showed improved skills, effi-
cient use of laboratory resources and reduction in both
costly overtreatment and potentially life threatening in-
appropriate treatment of malaria patients [28,51,52].
Large databases collected by hundreds of busy individ-
uals must be interpreted with caution. Although missing
information, potential erroneous diagnoses [21,23,24],
ability to classify diseases according to the ICD-10 which
was limited by lack of specificity of diagnosis recorded
on the MF5, errors in transcription and inadequacies of
the MF5 instrument itself can be considered a potential
limitation of our study, this large database of outpatient
visits provides a unique opportunity to better under-
stand routine care practices, particularly in rural areas.
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This analysis provides evidence that there is ample room
for improvement in primary care, both for the treatment
of infectious and, increasing NCD in rural Uganda. A
strong national HMIS has the potential to enable timely
collection of high quality BOD data that improves dis-
ease surveillance, curtails outbreaks and informs devel-
opment of national guidelines, programs, and policies
that are cost-effective, efficient and focused on local con-
ditions. Such information could then be used to ensure
accountability in the health sector and leverage improve-
ments in the quality of care.Additional files
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